Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,612 | 50,228 | 68,849 | 23,048 | 37,811 |
| Marketable Securities | 72,946 | 110,773 | 54,247 | 133,394 | 164,869 |
| Receivables | 6,397 | 6,571 | 5,143 | 4,544 | 2,815 |
| TOTAL | $98,748 | $171,505 | $133,132 | $166,442 | $206,032 |
| Non-Current Assets | |||||
| PPE Net | 84,573 | 83,676 | 37,362 | 26,707 | 14,477 |
| Investments And Advances | 0 | 0 | 0 | 10,398 | 0 |
| Intangibles | 27,638 | 28,838 | 30,038 | 31,238 | 0 |
| Other Non-Current Assets | 1,021 | 180 | 1,240 | 5,205 | 184 |
| TOTAL | $113,232 | $112,694 | $68,640 | $73,548 | $14,661 |
| Total Assets | $211,980 | $284,199 | $201,772 | $239,990 | $220,693 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,691 | N/A | N/A | N/A | 1,012 |
| Accounts payable and accrued liabilities | 7,574 | 5,884 | 4,378 | 3,168 | 2,523 |
| Accrued Expenses | 6,945 | 4,757 | 4,161 | 5,016 | 3,024 |
| TOTAL | $38,710 | $31,766 | $21,299 | $18,779 | $11,231 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,940 | 56,344 | 4,000 | N/A | 1,834 |
| Deferred Revenues | 19,500 | 21,125 | 12,760 | 10,595 | 4,672 |
| Other Non-Current Liabilities | 644 | 3,306 | 684 | 339 | 0 |
| TOTAL | $51,676 | $86,217 | $10,571 | $2,839 | $1,834 |
| Total Liabilities | $90,386 | $117,983 | $31,870 | $21,618 | $13,065 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,080 | 9,047 | 7,484 | 7,459 | N/A |
| Common Shares | 63 | 63 | 52 | 52 | 48 |
| Retained earnings | -261,115 | -213,943 | -149,745 | -90,075 | -54,903 |
| Other shareholders' equity | -20 | -899 | -11,106 | -22,697 | -33,637 |
| TOTAL | $121,594 | $166,216 | $169,902 | $218,372 | $207,628 |
| Total Liabilities And Equity | $211,980 | $284,199 | $201,772 | $239,990 | $220,693 |